Literature DB >> 19526528

Disability in IBD: the devil is in the details.

Joseph Sellin.   

Abstract

Mesh:

Year:  2010        PMID: 19526528     DOI: 10.1002/ibd.21014

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


× No keyword cloud information.
  5 in total

1.  IBD-related work disability in the community: Prevalence, severity and predictive factors. A cross-sectional study.

Authors:  Alexis Ramos; Xavier Calvet; Beatriz Sicilia; Mercedes Vergara; Ariadna Figuerola; Jaume Motos; Adoración Sastre; Albert Villoria; Fernando Gomollón
Journal:  United European Gastroenterol J       Date:  2015-08       Impact factor: 4.623

2.  JNK Pathway-Associated Phosphatase/DUSP22 Suppresses CD4+ T-Cell Activation and Th1/Th17-Cell Differentiation and Negatively Correlates with Clinical Activity in Inflammatory Bowel Disease.

Authors:  Rui Zhou; Ying Chang; Jing Liu; Min Chen; Hongling Wang; Meifang Huang; Shi Liu; Xiaobing Wang; Qiu Zhao
Journal:  Front Immunol       Date:  2017-07-04       Impact factor: 7.561

3.  Disability in Inflammatory Bowel Disease: Translation to Portuguese and Validation of the "Inflammatory Bowel Disease - Disability Score".

Authors:  Joana Magalhães; Francisca Dias de Castro; Pedro Boal Carvalho; João Firmino Machado; Sílvia Leite; Maria João Moreira; José Cotter
Journal:  GE Port J Gastroenterol       Date:  2015-01-07

4.  Medication non-adherence in inflammatory bowel diseases is associated with disability.

Authors:  Jonathan Perry; Andy Chen; Viraj Kariyawasam; Glen Collins; Chee Choong; Wei Ling Teh; Nikola Mitrev; Friedbert Kohler; Rupert Wing Loong Leong
Journal:  Intest Res       Date:  2018-10-10

5.  Real-world data about emotional stress, disability and need for social care in a German IBD patient cohort.

Authors:  Alica Kubesch; Patric Boulahrout; Natalie Filmann; Irina Blumenstein; Johannes Hausmann
Journal:  PLoS One       Date:  2020-01-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.